DECOR Information for Project: CDA-CH-VACD - Immunization Content (eVACDOC) (cdachvacd-)

Templates

HTML Name Effective Date Version Label
Templates with direct association to a transaction
html active Immunization Administration 2.16.756.5.30.1.1.10.1.16 2020‑06‑26 2020
Swiss eVACDOC - Immunization Administration
Transaction Direction Underlying Model Schematron
CDA-CH-VACD - Immunization Administration arrowright initial ClinicalDocument cdachvacd-Administration.sch
html active Immunization Certificate 2.16.756.5.30.1.1.10.1.15 2020‑06‑26 2020
Swiss eVACDOC - Immunization Certificate
Transaction Direction Underlying Model Schematron
CDA-CH-VACD - Immunization Certificate arrowright initial ClinicalDocument cdachvacd-Certificate.sch
html active Immunization Recommendation Request 2.16.756.5.30.1.1.10.1.17 2020‑06‑26 2020
Swiss eVACDOC - Immunization Recommendation Request
Transaction Direction Underlying Model Schematron
CDA-CH-VACD - Immunization Recommendation Request arrowright initial ClinicalDocument cdachvacd-RecommendationRequest.sch
html active Immunization Recommendation Response 2.16.756.5.30.1.1.10.1.18 2020‑06‑26 2020
Swiss eVACDOC - Immunization Recommendation Response
Transaction Direction Underlying Model Schematron
CDA-CH-VACD - Immunization Recommendation Response arrowright initial ClinicalDocument cdachvacd-RecommendationResponse.sch
html active Vaccination Record 2.16.756.5.30.1.1.10.1.19 2020‑06‑26 2020
Swiss eVACDOC - Vaccination Record
Transaction Direction Underlying Model Schematron
CDA-CH-VACD - Vaccination Record arrowright initial ClinicalDocument cdachvacd-VaccinationRecord.sch
CDA Document Level Template
  ref Immunization Administration 2.16.756.5.30.1.1.10.1.16 Multiple (2)  
Swiss eVACDOC - Immunization Administration
html active Immunization Administration 2.16.756.5.30.1.1.10.1.16 2020‑06‑26 2020
html rejected Immunization Administration 2.16.756.5.30.1.1.10.1.16 2018‑04‑19 2018
  ref Immunization Certificate 2.16.756.5.30.1.1.10.1.15 Multiple (2)  
Swiss eVACDOC - Immunization Certificate
html active Immunization Certificate 2.16.756.5.30.1.1.10.1.15 2020‑06‑26 2020
html rejected Immunization Certificate 2.16.756.5.30.1.1.10.1.15 2018‑04‑19 2018
  ref Immunization Recommendation Request 2.16.756.5.30.1.1.10.1.17 Multiple (2)  
Swiss eVACDOC - Immunization Recommendation Request
html active Immunization Recommendation Request 2.16.756.5.30.1.1.10.1.17 2020‑06‑26 2020
html rejected Immunization Recommendation Request 2.16.756.5.30.1.1.10.1.17 2018‑04‑19 2018
  ref Immunization Recommendation Response 2.16.756.5.30.1.1.10.1.18 Multiple (2)  
Swiss eVACDOC - Immunization Recommendation Response
html active Immunization Recommendation Response 2.16.756.5.30.1.1.10.1.18 2020‑06‑26 2020
html rejected Immunization Recommendation Response 2.16.756.5.30.1.1.10.1.18 2018‑04‑19 2018
  ref Vaccination Record 2.16.756.5.30.1.1.10.1.19 Multiple (2)  
Swiss eVACDOC - Vaccination Record
html active Vaccination Record 2.16.756.5.30.1.1.10.1.19 2020‑06‑26 2020
html rejected Vaccination Record 2.16.756.5.30.1.1.10.1.19 2018‑04‑19 2018
CDA Header Level Template
  ref Authenticator 2.16.756.5.30.1.1.10.2.6 Multiple (2)  
Information about an authenticator of a CDA document. An authenticator MUST be a person. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template by either reference or specialisa...
html active Authenticator 2.16.756.5.30.1.1.10.2.6
ref
hl7chcda-
 		2019‑01‑01 20:20:44 2020
html retired Authenticator 2.16.756.5.30.1.1.10.2.6
ref
hl7chcda-
 		2018‑04‑18 2017
  ref Custodian 2.16.756.5.30.1.1.10.2.3 Multiple (2)  
The organization in whose name this CDA document has been created (corresponds to the sender of a letter). All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template by either refer...
html active Custodian 2.16.756.5.30.1.1.10.2.3
ref
hl7chcda-
 		2019‑10‑15 09:26:07 2020
html retired Custodian 2.16.756.5.30.1.1.10.2.3
ref
hl7chcda-
 		2018‑04‑18 2017
html active Data Enterer 2.16.756.5.30.1.1.10.2.7
ref
hl7chcda-
 		2018‑04‑18 2017
Information about the person that entered information in this CDA document. It SHALL be declared, when data recorded in this document has been entered by a person other than the author but only when t...
  ref Document Code 2.16.756.5.30.1.1.10.2.63 Multiple (2)  
A LOINC based document type of a CDA document instance including a translation to the Swiss EPR XDS.b metadata. The LOINC code of the document MUST read: 11369-6 (H...
html active Document Code 2.16.756.5.30.1.1.10.2.63 2020‑06‑26 2020
html rejected Document Code 2.16.756.5.30.1.1.10.2.63 2018‑04‑19 2018
  ref Document Confidentiality Code 2.16.756.5.30.1.1.10.2.19 Multiple (2)  
A confidentiality level of a CDA document instance according to the Swiss EPR regulation. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST reference this template. Langu...
html active Document Confidentiality Code 2.16.756.5.30.1.1.10.2.19
ref
hl7chcda-
 		2019‑09‑12 14:08:42 2019
html retired Document Confidentiality Code 2.16.756.5.30.1.1.10.2.19
ref
hl7chcda-
 		2018‑04‑18 2017
  ref Document Language 2.16.756.5.30.1.1.10.2.22 Multiple (4)  
The language in which the narrative texts in this CDA document instance are written. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST reference this template.
html active Document Language 2.16.756.5.30.1.1.10.2.22
ref
hl7chcda-
 		2019‑09‑12 14:28:13 2020
html cancelled Document Language 2.16.756.5.30.1.1.10.2.22
ref
hl7chcda-
 		2019‑09‑12 14:27:38 2019
html cancelled Document Language 2.16.756.5.30.1.1.10.2.22
ref
hl7chcda-
 		2019‑09‑12 14:25:02 2019
html retired Document Language 2.16.756.5.30.1.1.10.2.22
ref
hl7chcda-
 		2018‑04‑18 2017
html active Document Realm 2.16.756.5.30.1.1.10.2.25
ref
hl7chcda-
 		2018‑04‑18 2017
Swiss Realm (CHE) of HL7 CDA. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST reference this template.
  ref Document Replacement - relatedDocument 2.16.756.5.30.1.1.10.2.13 Multiple (2)  
Relationship to another CDA-CH V2 based document that is replaced by the current one. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST reference this template.
html active Document Replacement - relatedDocument 2.16.756.5.30.1.1.10.2.13
ref
hl7chcda-
 		2019‑01‑01 21:22:58 2020
html retired Document Replacement - relatedDocument 2.16.756.5.30.1.1.10.2.13
ref
hl7chcda-
 		2018‑04‑18 2017
html active Document Set Id and Version Number 2.16.756.5.30.1.1.10.2.20
ref
hl7chcda-
 		2018‑04‑18 2017
Unity of document versions. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST reference this template.
  ref Document Template Ids CDA-CH v2.0 - structuredBody 2.16.756.5.30.1.1.10.2.18 Multiple (2)  
CDA-CH V2 bases on HL7 CDA R2 (2005) and - by using this template - require a structured body. All CDA-CH V2 derivatives, i.e. Swiss exchange formats SHALL reference this template. These SHALL define...
html active Document Template Ids CDA-CH v2.0 - structuredBody 2.16.756.5.30.1.1.10.2.18
ref
hl7chcda-
 		2019‑10‑17 15:21:50 2020
html retired Document Template Ids CDA-CH v2.0 - structuredBody 2.16.756.5.30.1.1.10.2.18
ref
hl7chcda-
 		2018‑04‑18 2017
html active Document Template Ids CDA-CH-VACD V2 for Swiss EPR 2.16.756.5.30.1.1.10.2.67 2020‑06‑26 2020
CDA-CH-VACD V2 bases on CDA-CH V2.1 (2020) and the Immunization Content profile (IHE PCC TF 11.0, 2016). This template defines the rules for documents to be published in the Swiss EPR.
html active Document Template Ids CDA-CH-VACD V2 non Swiss EPR 2.16.756.5.30.1.1.10.2.71 2020‑06‑26 2020
CDA-CH-VACD V2 bases on CDA-CH V2.1 (2020) and the Immunization Content profile (IHE PCC TF 11.0, 2016). This template defines the rules for documents that are not to be published in the Swiss EPR.
  ref Health Service - documentationOf 2.16.756.5.30.1.1.10.2.46 Multiple (2)  
Information about a health service describing the context of this CDA document. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template by either reference or specialisation.
html active Health Service - documentationOf 2.16.756.5.30.1.1.10.2.46
ref
hl7chcda-
 		2019‑01‑01 20:53:33 2019
html retired Health Service - documentationOf 2.16.756.5.30.1.1.10.2.46
ref
hl7chcda-
 		2018‑04‑18 2017
  ref Human Patient - recordTarget 2.16.756.5.30.1.1.10.2.68 Multiple (2)  
A human patient for whom this CDA document instance was created.
html active Human Patient - recordTarget 2.16.756.5.30.1.1.10.2.68 2020‑06‑26 2020
html rejected Human Patient - recordTarget 2.16.756.5.30.1.1.10.2.68 2018‑04‑19 2018
html active Insurance - participant 2.16.756.5.30.1.1.10.2.15
ref
hl7chcda-
 		2018‑04‑18 2017
Information on a patient's insurance. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialisation.
html active Insurance Card - participant 2.16.756.5.30.1.1.10.2.14
ref
hl7chcda-
 		2018‑04‑18 2017
Information on a patient's insurance card. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialisation.
html active Legal Authenticator 2.16.756.5.30.1.1.10.2.5
ref
hl7chcda-
 		2018‑04‑18 2017
Information about the legal authenticator of a CDA document. A legal authenticator MUST be a person. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template by either reference o...
  ref Masked Patient - recordTarget 2.16.756.5.30.1.1.10.2.69 Multiple (2)  
A human patient for whom this CDA document instance was created. Its demographic data is masked as much as possible. Only the demographic information (such as gender, birthdate and city) that is neede...
html active Masked Patient - recordTarget 2.16.756.5.30.1.1.10.2.69 2020‑06‑26 2020
html rejected Masked Patient - recordTarget 2.16.756.5.30.1.1.10.2.69 2018‑04‑19 2018
html active Order Reference - inFulfillmentOf 2.16.756.5.30.1.1.10.2.16
ref
hl7chcda-
 		2018‑04‑18 2017
Reference to one or more orders which led to the creation of this CDA document. It SHALL be declared, when the order reference is relevant for some reason. All CDA-CH V2 derivatives, i.e. Swiss exchan...
html active Recipient - informationRecipient 2.16.756.5.30.1.1.10.2.4
ref
hl7chcda-
 		2018‑04‑18 2017
A recipient of this CDA document (corresponds to the addressee of a letter - person or organization). All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template by either reference ...
CDA Section Level Template
  ref Active Problems Section - coded 2.16.756.5.30.1.1.10.3.25 Multiple (2)  
Chapter (CDA Body Section) containing the active problem list according to IHE PCC Technical Framework Revision 11.0 - November 11, 2016. This section MAY contain t...
html active Active Problems Section - coded 2.16.756.5.30.1.1.10.3.25
ref
ch-pcc-
 		2016‑11‑12 2016
html rejected Active Problems Section - coded 2.16.756.5.30.1.1.10.3.25
ref
ch-pcc-
 		2016‑11‑11 2016
  ref Allergies and other Adverse Reactions Section - coded 2.16.756.5.30.1.1.10.3.51 Multiple (2)  
Chapter (CDA Body Section) containing allergies and other adverse reactions according to IHE PCC Technical Framework Revision 11.0 - November 11, 2016. This section...
html active Allergies and other Adverse Reactions Section - coded 2.16.756.5.30.1.1.10.3.51
ref
ch-pcc-
 		2016‑11‑12 2016
html rejected Allergies and other Adverse Reactions Section - coded 2.16.756.5.30.1.1.10.3.51
ref
ch-pcc-
 		2016‑11‑11 2016
  ref Current Pregnancy Section - coded 2.16.756.5.30.1.1.10.3.53 Multiple (3)  
Chapter (CDA Body Section) containing the information about a current pregnancy. This section is specialisation of the Pregnancy Hostory section according to IHE PCC Technical Framew...
html rejected Current Pregnancy Section - coded 2.16.756.5.30.1.1.10.3.53
ref
ch-pcc-
 		2018‑04‑19 2018
html rejected Current Pregnancy Section - coded 2.16.756.5.30.1.1.10.3.53
ref
ch-pcc-
 		2016‑11‑12 2018
html active Current Pregnancy Section - coded 2.16.756.5.30.1.1.10.3.53
ref
ch-pcc-
 		2016‑11‑11 2018
  ref History Of Past Illness Section - coded 2.16.756.5.30.1.1.10.3.50 Multiple (2)  
Chapter (CDA Body Section) containing the history of past illness according to IHE PCC Technical Framework Revision 11.0 - November 11, 2016. This section contains ...
html active History Of Past Illness Section - coded 2.16.756.5.30.1.1.10.3.50
ref
ch-pcc-
 		2016‑11‑12 2016
html rejected History Of Past Illness Section - coded 2.16.756.5.30.1.1.10.3.50
ref
ch-pcc-
 		2016‑11‑11 2016
  ref Immunization Recommendations Section - coded 2.16.756.5.30.1.1.10.3.48 Multiple (2)  
Chapter (CDA Body Section) containing immunization recommendations according to IHE PCC Technical Framework Revision 11.0 - November 11, 2016. This section MAY cont...
html active Immunization Recommendations Section - coded 2.16.756.5.30.1.1.10.3.48
ref
ch-pcc-
 		2016‑11‑12 2016
html rejected Immunization Recommendations Section - coded 2.16.756.5.30.1.1.10.3.48
ref
ch-pcc-
 		2016‑11‑11 2016
  ref Immunizations Section - coded 2.16.756.5.30.1.1.10.3.47 Multiple (2)  
Chapter (CDA Body Section) containing immunizations according to IHE PCC Technical Framework Revision 11.0 - November 11, 2016. This section contains administered i...
html active Immunizations Section - coded 2.16.756.5.30.1.1.10.3.47
ref
ch-pcc-
 		2016‑11‑12 2016
html rejected Immunizations Section - coded 2.16.756.5.30.1.1.10.3.47
ref
ch-pcc-
 		2016‑11‑11 2016
  ref Laboratory Report Item Section - coded 2.16.756.5.30.1.1.10.3.5 Multiple (2)  
A Laboratory Specialty Section SHALL contain EITHER a list of Laboratory Report Item Section(s) OR a single text and entry element to represent the Report Items. ...
html active Laboratory Report Item Section - coded 2.16.756.5.30.1.1.10.3.5
ref
ch-palm-
 		2019‑08‑20 2019
html rejected Laboratory Report Item Section - coded 2.16.756.5.30.1.1.10.3.5
ref
ch-palm-
 		2017‑06‑21 2017
  ref Laboratory Speciality Section - coded 2.16.756.5.30.1.1.10.3.3 Multiple (2)  
Chapter (CDA Body Section) with laboratory results according to Sharing Laboratory Reports (XD-LAB) Content Module, IHE PaLM Technical Framework Revision 10.0 - August 20, 2019. Each Laboratory Spec...
html active Laboratory Speciality Section - coded 2.16.756.5.30.1.1.10.3.3
ref
ch-palm-
 		2019‑08‑20 2019
html rejected Laboratory Speciality Section - coded 2.16.756.5.30.1.1.10.3.3
ref
ch-palm-
 		2017‑06‑21 2017
  ref Other Relevant Observations Section - coded 2.16.756.5.30.1.1.10.3.46 Multiple (2)  
Chapter (CDA Body Section) containing the coded results according to IHE PCC Technical Framework Revision 11.0 - November 11, 2016. This section MAY contain relevan...
html active Other Relevant Observations Section - coded 2.16.756.5.30.1.1.10.3.46 2020‑06‑26 2020
html rejected Other Relevant Observations Section - coded 2.16.756.5.30.1.1.10.3.46 2018‑04‑19 2018
html active Remarks Section - coded 2.16.756.5.30.1.1.10.3.2
ref
hl7chcda-
 		2018‑04‑18 2017
This section MAY be used to provide comments, remarks or other information that cannot be declared in any of the other existing sections in the document.
CDA Entry Level Template
  ref Allergies and Intolerances Concern Entry 2.16.756.5.30.1.1.10.4.91 Multiple (2)  
This element is a specialization of 'Problem Concern' whereby the problem is focused on an allergy or intolerance. It therefore describes an allergy or intolerances...
html active Allergies and Intolerances Concern Entry 2.16.756.5.30.1.1.10.4.91
ref
ch-pcc-
 		2016‑11‑12 2016
html rejected Allergies and Intolerances Concern Entry 2.16.756.5.30.1.1.10.4.91
ref
ch-pcc-
 		2016‑11‑11 2016
  ref Allergy Or Intolerance Entry 2.16.756.5.30.1.1.10.4.98 Multiple (2)  
Allergies or intolerances are a special form of a 'Problem Entry'. In relation with immunizations, substances in vaccines SHALL be recorded here, using the WHO ATC ...
html active Allergy Or Intolerance Entry 2.16.756.5.30.1.1.10.4.98
ref
ch-pcc-
 		2016‑11‑12 2016
html rejected Allergy Or Intolerance Entry 2.16.756.5.30.1.1.10.4.98
ref
ch-pcc-
 		2016‑11‑11 2016
  ref Annotation Comments 2.16.756.5.30.1.1.10.4.2 Multiple (2)  
This entry allows for a comment to be supplied with each entry.
html active Annotation Comments 2.16.756.5.30.1.1.10.4.2
ref
ch-pcc-
 		2016‑11‑12 2016
html rejected Annotation Comments 2.16.756.5.30.1.1.10.4.2
ref
ch-pcc-
 		2016‑11‑11 2016
  ref Case Identification 2.16.756.5.30.1.1.10.4.15 Multiple (2)  
If an examination belongs to a specific case, this CAN be documented with this element (in the Notification Organizer).
html active Case Identification 2.16.756.5.30.1.1.10.4.15
ref
ch-palm-
 		2019‑08‑20 2019
html rejected Case Identification 2.16.756.5.30.1.1.10.4.15
ref
ch-palm-
 		2017‑06‑21 2017
  ref Device - participant Containment 2.16.756.5.30.1.1.10.4.10 Multiple (2)  
Declaration of analyzer, test kit and manufacturer used to determine the result. All participating elements (including devices), MUST according to XD-LAB contain name, addr and telecom.
html active Device - participant Containment 2.16.756.5.30.1.1.10.4.10
ref
ch-palm-
 		2019‑08‑20 2020
html rejected Device - participant Containment 2.16.756.5.30.1.1.10.4.10
ref
ch-palm-
 		2017‑06‑21 2017
html active External document 2.16.756.5.30.1.1.10.4.29
ref
hl7chcda-
 		2018‑04‑18 2017
External documents can be included in a CDA document, either by means of references or by means of XML embedding. This template defines a reference to an external document, only. Embedded documents...
  ref Gestational Age At Birth 2.16.756.5.30.1.1.10.4.84 Multiple (2)  
The coded gestational age in days of gestation at birth of a patient. This item is intended to be applied for the child but not for the mother.
html active Gestational Age At Birth 2.16.756.5.30.1.1.10.4.84 2020‑06‑26 2020
html rejected Gestational Age At Birth 2.16.756.5.30.1.1.10.4.84 2018‑04‑19 2018
  ref Human Patient with Non-Human Subject - subject Containment 2.16.756.5.30.1.1.10.4.6 Multiple (2)  
If, in a part of the document, certain laboratory observations for a human patient base on a sample of a non-human material (e.g., food eaten by the patient or an animal that has bitten the patient), ...
html active Human Patient with Non-Human Subject - subject Containment 2.16.756.5.30.1.1.10.4.6
ref
ch-palm-
 		2019‑08‑20 2019
html rejected Human Patient with Non-Human Subject - subject Containment 2.16.756.5.30.1.1.10.4.6
ref
ch-palm-
 		2017‑06‑21 2017
html active IHE Antigen Dose entry 1.3.6.1.4.1.19376.1.5.3.1.4.12.1
ref
IHE-PCC-
 		2016‑09‑28 13:50:21 2014
An Antigen Dose entry is used to record additional details about the patient's immunization history. These entries may be used to provide dose details about a specific antigen received during an Immun...
html active IHE Product Entry 1.3.6.1.4.1.19376.1.5.3.1.4.7.2
ref
IHE-PCC-
 		2016‑01‑08 12:51:58 2014
The product entry describes a medication or immunization used in a <substanceAdministration>  or <supply> act. It adopts the constraints of the ASTM/HL7 Continuity of Care Document. ...
  ref Immunization Entry 2.16.756.5.30.1.1.10.4.89 Multiple (2)  
An immunizations entry is used to record the patient's immunization history. An immunization is a substance administration event. An immunization entry may also be used to report a specific immunizati...
html active Immunization Entry 2.16.756.5.30.1.1.10.4.89
ref
ch-pcc-
 		2016‑11‑12 2016
html rejected Immunization Entry 2.16.756.5.30.1.1.10.4.89
ref
ch-pcc-
 		2016‑11‑11 2016
html active Immunization Performer - performer Containment 2.16.756.5.30.1.1.10.4.101
ref
ch-pcc-
 		2016‑11‑11 2016
Health professional that administered the immunization.
  ref Immunization Recommendation Entry 2.16.756.5.30.1.1.10.4.93 Multiple (2)  
An immunization recommendation entry is used to record the patient's immunization plan. An immunization recommendation is a substance administration proposal or a documentation of an intended, but not...
html active Immunization Recommendation Entry 2.16.756.5.30.1.1.10.4.93
ref
ch-pcc-
 		2016‑11‑12 2016
html rejected Immunization Recommendation Entry 2.16.756.5.30.1.1.10.4.93
ref
ch-pcc-
 		2016‑11‑11 2016
  ref Immunization Series Number 2.16.756.5.30.1.1.10.4.119 Multiple (2)  
Immunization Series Number
html cancelled Immunization Series Number 2.16.756.5.30.1.1.10.4.119
ref
ch-pcc-
 		2020‑04‑28 10:47:56 2016
html active Immunization Series Number 2.16.756.5.30.1.1.10.4.119
ref
ch-pcc-
 		2016‑11‑12 2016
  ref Laboratory Battery Organizer 2.16.756.5.30.1.1.10.4.19 Multiple (2)  
According to IHE XD-LAB, the Laboratory Battery Organizer allows the grouping of results. Laboratory reports MUST contain at least one result group with at least one result. The grouping of multipl...
html active Laboratory Battery Organizer 2.16.756.5.30.1.1.10.4.19
ref
ch-palm-
 		2019‑08‑20 2019
html rejected Laboratory Battery Organizer 2.16.756.5.30.1.1.10.4.19
ref
ch-palm-
 		2017‑06‑21 2017
  ref Laboratory Isolate Organizer 2.16.756.5.30.1.1.10.4.17 Multiple (2)  
The Laboratory Isolate Organizer MUST ONLY be used if it is a microbiological specimen with which isolates/germs were examined.
html active Laboratory Isolate Organizer 2.16.756.5.30.1.1.10.4.17
ref
ch-palm-
 		2019‑08‑20 2019
html rejected Laboratory Isolate Organizer 2.16.756.5.30.1.1.10.4.17
ref
ch-palm-
 		2017‑06‑21 2017
  ref Laboratory Observation 2.16.756.5.30.1.1.10.4.3 Multiple (2)  
Laboratory reports MUST contain at least one laboratory result which is declared using this element. Each laboratory result consists of code, value and interpretation of the result. ...
html active Laboratory Observation 2.16.756.5.30.1.1.10.4.3
ref
ch-palm-
 		2019‑08‑20 2020
html rejected Laboratory Observation 2.16.756.5.30.1.1.10.4.3
ref
ch-palm-
 		2017‑06‑21 2017
  ref Laboratory Performer - performer Containment 2.16.756.5.30.1.1.10.4.7 Multiple (2)  
This CAN be used to indicate another executing laboratory in the CDA body. When executing laboratories are specified, the following applies: If all tests have...
html active Laboratory Performer - performer Containment 2.16.756.5.30.1.1.10.4.7
ref
ch-palm-
 		2019‑08‑20 2019
html rejected Laboratory Performer - performer Containment 2.16.756.5.30.1.1.10.4.7
ref
ch-palm-
 		2017‑06‑21 2017
  ref Laboratory Report Data Processing Entry 2.16.756.5.30.1.1.10.4.4 Multiple (2)  
Each chapter (Laboratory Speciality Section and Laboratory Report Item Section) MUST contain exactly one findings group (CDA Body Laboratory Report Data Processing Entry).
html active Laboratory Report Data Processing Entry 2.16.756.5.30.1.1.10.4.4
ref
ch-palm-
 		2019‑08‑20 2019
html rejected Laboratory Report Data Processing Entry 2.16.756.5.30.1.1.10.4.4
ref
ch-palm-
 		2017‑06‑21 2017
  ref Laboratory Results Validator - participant Containment 2.16.756.5.30.1.1.10.4.8 Multiple (2)  
The document MAY contain further signatures (besides the legal authenticator). A Laboratory Results Validator is such an authenticator. It is a laboratory specialist who has performe...
html active Laboratory Results Validator - participant Containment 2.16.756.5.30.1.1.10.4.8
ref
ch-palm-
 		2019‑08‑20 2019
html rejected Laboratory Results Validator - authenticator/participant Containment 2.16.756.5.30.1.1.10.4.8
ref
ch-palm-
 		2017‑06‑21 2017
  ref Manufactured Product 2.16.756.5.30.1.1.10.4.94 Multiple (2)  
Structured information on a product (e.g. Vaccine or Medication). Trade name of the product SHALL be present in the element 'name' of manufact...
html active Manufactured Product 2.16.756.5.30.1.1.10.4.94
ref
ch-pcc-
 		2016‑11‑12 2016
html rejected Manufactured Product 2.16.756.5.30.1.1.10.4.94
ref
ch-pcc-
 		2016‑11‑11 2016
  ref Multimedia Embedded Content 2.16.756.5.30.1.1.10.4.18 Multiple (2)  
Multimedia objects (e.g., PDF representations of the CDA document, pictures, Reiber diagrams, electrophoresis, etc.) MAY be integrated into a CDA document, either by reference to ext...
html active Multimedia Embedded Content 2.16.756.5.30.1.1.10.4.18
ref
ch-palm-
 		2019‑08‑20 2020
html rejected Multimedia Embedded Content 2.16.756.5.30.1.1.10.4.18
ref
ch-palm-
 		2017‑06‑21 2017
  ref Non-Human Subject - subject Containment 2.16.756.5.30.1.1.10.4.5 Multiple (2)  
If, in a part of the document, laboratory obseravtions base exclusively on a sample of a non-human material (e.g., animal, water, soil, etc.) without reference to a patient, it MUST be declared using...
html active Non-Human Subject - subject Containment 2.16.756.5.30.1.1.10.4.5
ref
ch-palm-
 		2019‑08‑20 2019
html rejected Non-Human Subject - subject Containment 2.16.756.5.30.1.1.10.4.5
ref
ch-palm-
 		2017‑06‑21 2017
  ref Notifiable Condition 2.16.756.5.30.1.1.10.4.14 Multiple (2)  
If a reportable condition is given (e.g., according to the Federal Act on Combating Communicable Human Diseases and the associated ordinance), this CAN be declared in the CDA body using this element.
html active Notifiable Condition 2.16.756.5.30.1.1.10.4.14
ref
ch-palm-
 		2019‑08‑20 2019
html rejected Notifiable Condition 2.16.756.5.30.1.1.10.4.14
ref
ch-palm-
 		2017‑06‑21 2017
  ref Notification Organizer 2.16.756.5.30.1.1.10.4.13 Multiple (2)  
A laboratory report MAY contain information on the obligation to report pathogen detection, on accumulation of observations or specific epidemiologically relevant events. ...
html active Notification Organizer 2.16.756.5.30.1.1.10.4.13
ref
ch-palm-
 		2019‑08‑20 2019
html rejected Notification Organizer 2.16.756.5.30.1.1.10.4.13
ref
ch-palm-
 		2017‑06‑21 2017
  ref Outbreak Identification 2.16.756.5.30.1.1.10.4.16 Multiple (2)  
If an examination falls under the category "accumulation of observations" or "specific epidemiologically relevant event", this CAN be declared in the CDA body using this element. ...
html active Outbreak Identification 2.16.756.5.30.1.1.10.4.16
ref
ch-palm-
 		2019‑08‑20 2019
html rejected Outbreak Identification 2.16.756.5.30.1.1.10.4.16
ref
ch-palm-
 		2017‑06‑21 2017
  ref Pregnancy Observation Delivery Date 2.16.756.5.30.1.1.10.4.102 Multiple (2)  
This element contains structured information about the delivery date of a pregnancy.
html rejected Pregnancy Observation Delivery Date 2.16.756.5.30.1.1.10.4.102
ref
ch-pcc-
 		2018‑04‑19 2018
html active Pregnancy Observation Delivery Date 2.16.756.5.30.1.1.10.4.102
ref
ch-pcc-
 		2016‑11‑12 2018
html active Pregnancy Observation Entry 2.16.756.5.30.1.1.10.4.92
ref
ch-pcc-
 		2016‑11‑12 2016
This element contains structured information about a pregnancy.
  ref Previous Observation 2.16.756.5.30.1.1.10.4.22 Multiple (2)  
A laboratory result can be supplemented with any number of previous results, if this information is important. Previous laboratory results MUST be associated to the same patient, the same test, the sa...
html active Previous Observation 2.16.756.5.30.1.1.10.4.22
ref
ch-palm-
 		2019‑08‑20 2019
html rejected Previous Observation 2.16.756.5.30.1.1.10.4.22
ref
ch-palm-
 		2017‑06‑21 2017
  ref Problem Concern Entry 2.16.756.5.30.1.1.10.4.90 Multiple (2)  
This element describes a problem concern of the patient and indicates the period of time where this concern is active. It contains a set of references to problems related to this concern. In the conte...
html active Problem Concern Entry 2.16.756.5.30.1.1.10.4.90
ref
ch-pcc-
 		2016‑11‑12 2016
html rejected Problem Concern Entry 2.16.756.5.30.1.1.10.4.90
ref
ch-pcc-
 		2016‑11‑11 2016
  ref Problem Entry 2.16.756.5.30.1.1.10.4.97 Multiple (2)  
Problem as structured entry (e.g. syptom, complaint, diagnosis etc.)
html active Problem Entry 2.16.756.5.30.1.1.10.4.97
ref
ch-pcc-
 		2016‑11‑12 2016
html rejected Problem Entry 2.16.756.5.30.1.1.10.4.97
ref
ch-pcc-
 		2016‑11‑11 2016
  ref Problem Status Observation 2.16.756.5.30.1.1.10.4.100 Multiple (2)  
Any problem or allergy observation may reference a problem status observation.
html active Problem Status Observation 2.16.756.5.30.1.1.10.4.100
ref
ch-pcc-
 		2016‑11‑12 2016
html rejected Problem Status Observation 2.16.756.5.30.1.1.10.4.100
ref
ch-pcc-
 		2016‑11‑11 2016
  ref Reaction Observation 2.16.756.5.30.1.1.10.4.120 Multiple (2)  
Reaction as structured entry
html rejected Reaction Observation 2.16.756.5.30.1.1.10.4.120
ref
ch-pcc-
 		2020‑04‑29 12:47:35 2016
html active Reaction Observation 2.16.756.5.30.1.1.10.4.120
ref
ch-pcc-
 		2016‑11‑12 2016
html active Recommendation Category - Criterion 2.16.756.5.30.1.1.10.4.96
ref
ch-pcc-
 		2018‑04‑19 2018
Recommendation category according to the Swiss vaccination plan.
  ref Responsible Party - participant Containment 2.16.756.5.30.1.1.10.4.9 Multiple (2)  
External laboratory that has delivered the results. The following applies: The external laboratory MUST be declared, including its responsible person. All...
html active Responsible Party - participant Containment 2.16.756.5.30.1.1.10.4.9
ref
ch-palm-
 		2019‑08‑20 2019
html rejected Responsible Party - participant Containment 2.16.756.5.30.1.1.10.4.9
ref
ch-palm-
 		2017‑06‑21 2017
  ref Severity Entry 2.16.756.5.30.1.1.10.4.99 Multiple (2)  
Declaration of the severity of a problem or an allergy/intolerance
html active Severity Entry 2.16.756.5.30.1.1.10.4.99
ref
ch-pcc-
 		2016‑11‑12 2016
html rejected Severity Entry 2.16.756.5.30.1.1.10.4.99
ref
ch-pcc-
 		2016‑11‑11 2016
  ref Specimen Collection 2.16.756.5.30.1.1.10.4.11 Multiple (2)  
Laboratory reports MAY contain information on the specimen. If there are more than one specimen associated to the order, then this item occurs multiple times.
html active Specimen Collection 2.16.756.5.30.1.1.10.4.11
ref
ch-palm-
 		2019‑08‑20 2019
html rejected Specimen Collection 2.16.756.5.30.1.1.10.4.11
ref
ch-palm-
 		2017‑06‑21 2017
  ref Specimen collection - participant Containment 2.16.756.5.30.1.1.10.4.24 Multiple (2)  
Specimen Information.
html active Specimen collection - participant Containment 2.16.756.5.30.1.1.10.4.24
ref
ch-palm-
 		2019‑08‑20 2019
html rejected Specimen collection - participant Containment 2.16.756.5.30.1.1.10.4.24
ref
ch-palm-
 		2017‑06‑21 2017
  ref Specimen Received 2.16.756.5.30.1.1.10.4.12 Multiple (2)  
A laboratory report MAY contain information on the reception of the specimen at the laboratory.
html active Specimen Received 2.16.756.5.30.1.1.10.4.12
ref
ch-palm-
 		2019‑08‑20 2019
html rejected Specimen Received 2.16.756.5.30.1.1.10.4.12
ref
ch-palm-
 		2017‑06‑21 2017
  ref Specimen Type 2.16.756.5.30.1.1.10.4.27 Multiple (2)  
Specimen Type.
html active Specimen Type 2.16.756.5.30.1.1.10.4.27
ref
ch-palm-
 		2019‑08‑20 2020
html rejected Specimen Type 2.16.756.5.30.1.1.10.4.27
ref
ch-palm-
 		2017‑06‑21 2017
  ref Target Of The Immunization - Medication Target 2.16.756.5.30.1.1.10.4.95 Multiple (2)  
Target of the immunization. All immunizations targets (diseases) SHALL be recorded with an immunization entry. This element allows structured information for immunizations with combinded vaccines (e.g...
html rejected Target Of The Immunization - Medication Target 2.16.756.5.30.1.1.10.4.95
ref
ch-pcc-
 		2018‑04‑19 2018
html active Target Of The Immunization - Medication Target 2.16.756.5.30.1.1.10.4.95
ref
ch-pcc-
 		2016‑11‑12 2018
Template type not specified
html active Address Information Compilation - eCH-0010 2.16.756.5.30.1.1.10.9.35
ref
hl7chcda-
 		2018‑04‑18 2017
Address information according to the eCH-0010 V7.0 addressInformation data type. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialisation. See h...
  ref Assigned Entity Compilation with GLN and name 2.16.756.5.30.1.1.10.9.51 Multiple (2)  
Reusable template wherever an assigned entity with a required GLN is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or speci...
html active Assigned Entity Compilation with GLN and name 2.16.756.5.30.1.1.10.9.51
ref
hl7chcda-
 		2019‑10‑24 16:53:35 2020
html retired Assigned Entity Compilation with GLN and name 2.16.756.5.30.1.1.10.9.51
ref
hl7chcda-
 		2018‑04‑18 2017
  ref Assigned Entity Compilation with GLN, name, addr, telecom, person and organization 2.16.756.5.30.1.1.10.9.50 Multiple (2)  
Reusable template wherever an assigned entity with required GLN, name, addr, telecom, person and organization (also with GLN) are used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchan...
html active Assigned Entity Compilation with GLN, name, addr, telecom, person and organization 2.16.756.5.30.1.1.10.9.50
ref
hl7chcda-
 		2019‑10‑24 16:50:31 2020
html retired Assigned Entity Compilation with GLN, name, addr, telecom, person and organization 2.16.756.5.30.1.1.10.9.50
ref
hl7chcda-
 		2018‑04‑18 2017
  ref Assigned Entity Compilation with id 2.16.756.5.30.1.1.10.9.12 Multiple (2)  
Reusable template wherever an assigned entity with a required id is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specia...
html active Assigned Entity Compilation with id 2.16.756.5.30.1.1.10.9.12
ref
hl7chcda-
 		2019‑10‑24 16:41:55 2020
html retired Assigned Entity Compilation with id 2.16.756.5.30.1.1.10.9.12
ref
hl7chcda-
 		2018‑04‑18 2017
  ref Assigned Entity Compilation with id, name, addr, telecom, person and organization 2.16.756.5.30.1.1.10.9.32 Multiple (2)  
Reusable template wherever an assigned entity with required id, name, addr, telecom, person and organization are used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY us...
html active Assigned Entity Compilation with id, name, addr, telecom, person and organization 2.16.756.5.30.1.1.10.9.32
ref
hl7chcda-
 		2019‑10‑24 16:38:14 2020
html retired Assigned Entity Compilation with id, name, addr, telecom, person and organization 2.16.756.5.30.1.1.10.9.32
ref
hl7chcda-
 		2018‑04‑18 2017
  ref Assigned Entity Compilation with name, addr and telecom 2.16.756.5.30.1.1.10.9.17 Multiple (2)  
Reusable template wherever an assigned entity with required name, addr and telecom is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either r...
html active Assigned Entity Compilation with name, addr and telecom 2.16.756.5.30.1.1.10.9.17
ref
hl7chcda-
 		2019‑10‑24 16:20:55 2020
html retired Assigned Entity Compilation with name, addr and telecom 2.16.756.5.30.1.1.10.9.17
ref
hl7chcda-
 		2018‑04‑18 2017
  ref Author 2.16.756.5.30.1.1.10.9.23 Multiple (2)  
Information about the author of a CDA document, section or entry. An author MAY be a person or a device. All CDA-CH V2 derivatives, i.e. Swiss exchange formats MUST use this template at least in the C...
html active Author 2.16.756.5.30.1.1.10.9.23
ref
hl7chcda-
 		2019‑09‑12 13:48:28 2020
html retired Author 2.16.756.5.30.1.1.10.9.23
ref
hl7chcda-
 		2018‑04‑18 2017
html active Author Compilation with id, name, addr and telecom 2.16.756.5.30.1.1.10.9.54
ref
hl7chcda-
 		2020‑04‑28 12:02:52 2020
Reusable template wherever an author with required name, addr and telecom is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference ...
  ref Author Compilation with name 2.16.756.5.30.1.1.10.9.48 Multiple (2)  
Reusable template wherever an author with required name is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialisation.
html active Author Compilation with name 2.16.756.5.30.1.1.10.9.48
ref
hl7chcda-
 		2019‑10‑24 15:57:29 2020
html retired Author Compilation with name 2.16.756.5.30.1.1.10.9.48
ref
hl7chcda-
 		2018‑04‑18 2017
  ref Author Compilation with name, addr and telecom 2.16.756.5.30.1.1.10.9.16 Multiple (2)  
Reusable template wherever an author with required name, addr and telecom is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference ...
html active Author Compilation with name, addr and telecom 2.16.756.5.30.1.1.10.9.16
ref
hl7chcda-
 		2019‑10‑24 16:13:06 2020
html retired Author Compilation with name, addr and telecom 2.16.756.5.30.1.1.10.9.16
ref
hl7chcda-
 		2018‑04‑18 2017
html active Device Compilation with name 2.16.756.5.30.1.1.10.9.21
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever a device with required name is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialisation....
html active Narrative Text Reference 2.16.756.5.30.1.1.10.9.14
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever a text reference to the corresponding text in the human readable part (narrative text) is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MA...
html active Organization Compilation with GLN and name 2.16.756.5.30.1.1.10.9.30
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever an organization with required GLN as id and name is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either referenc...
html active Organization Compilation with GLN, name, addr and telecom 2.16.756.5.30.1.1.10.9.26
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever an organization with required GLN as id, name, address and communication means is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use th...
html active Organization Compilation with id, name, addr and telecom 2.16.756.5.30.1.1.10.9.33
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever an organization with required id, name, address and communication means is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this temp...
html active Organization Compilation with name 2.16.756.5.30.1.1.10.9.24
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever an organization with required name is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specialis...
html active Organization Compilation with name, addr, telecom 2.16.756.5.30.1.1.10.9.27
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever an organization with required name, address and communication means is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template...
html active Original Text Reference 2.16.756.5.30.1.1.10.9.49
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever a original text reference to the corresponding text in the human readable part (narrative text) is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange f...
  ref Performer 2.16.756.5.30.1.1.10.9.31 Multiple (2)  
Reusable template wherever a healthcare provider who was the primary performer of an act is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by ei...
html active Performer 2.16.756.5.30.1.1.10.9.31
ref
hl7chcda-
 		2018‑12‑24 19:51:04 2020
html retired Performer 2.16.756.5.30.1.1.10.9.31
ref
hl7chcda-
 		2018‑04‑18 2017
html active Person Name Information Compilation - eCH-0011 2.16.756.5.30.1.1.10.9.34
ref
hl7chcda-
 		2018‑04‑18 2017
Person name information (with required family and given name) according to the eCH-0011 V8.1 nameData data type. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either ref...
html active PlayingEntity Compilation with name 2.16.756.5.30.1.1.10.9.20
ref
hl7chcda-
 		2018‑04‑18 2017
Reusable template wherever a playing entity with a required name is used in a CDA-CH V2 document. CDA-CH V2 derivatives, i.e. Swiss exchange formats MAY use this template by either reference or specia...

Template Summary

Templates 168

Templates per Scenario

Templates for scenario CDA-CH-VACD cdachvacd-3 as of 2015‑12‑11

Transaction Representing template Link as of
CDA-CH-VACD - Immunization Administration 2.16.756.5.30.1.1.10.1.16 Immunization Administration 2020‑06‑26
CDA-CH-VACD - Immunization Certificate 2.16.756.5.30.1.1.10.1.15 Immunization Certificate 2020‑06‑26
CDA-CH-VACD - Immunization Recommendation Request 2.16.756.5.30.1.1.10.1.17 Immunization Recommendation Request 2020‑06‑26
CDA-CH-VACD - Immunization Recommendation Response 2.16.756.5.30.1.1.10.1.18 Immunization Recommendation Response 2020‑06‑26
CDA-CH-VACD - Vaccination Record 2.16.756.5.30.1.1.10.1.19 Vaccination Record 2020‑06‑26

Item Labels per Template

Label Template id Template name Link as of
6.3.4.19 link11 1.3.6.1.4.1.19376.1.5.3.1.4.7.2 IHE Product Entry 1.3.6.1.4.1.19376.1.5.3.1.4.7.2 2016‑01‑08 12:51:58
6.3.4.19.2 link11 1.3.6.1.4.1.19376.1.5.3.1.4.7.2 IHE Product Entry 1.3.6.1.4.1.19376.1.5.3.1.4.7.2 2016‑01‑08 12:51:58
6.3.4.19.2 link11 1.3.6.1.4.1.19376.1.5.3.1.4.7.2 IHE Product Entry 1.3.6.1.4.1.19376.1.5.3.1.4.7.2 2016‑01‑08 12:51:58
6.3.4.19.3 link11 1.3.6.1.4.1.19376.1.5.3.1.4.7.2 IHE Product Entry 1.3.6.1.4.1.19376.1.5.3.1.4.7.2 2016‑01‑08 12:51:58
6.3.4.51 link11 1.3.6.1.4.1.19376.1.5.3.1.4.12.1 IHE Antigen Dose entry 1.3.6.1.4.1.19376.1.5.3.1.4.12.1 2016‑09‑28 13:50:21
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.13 Document Replacement - relatedDocument 2.16.756.5.30.1.1.10.2.13 2019‑01‑01 21:22:58
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.13 Document Replacement - relatedDocument 2.16.756.5.30.1.1.10.2.13 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.14 Insurance Card - participant 2.16.756.5.30.1.1.10.2.14 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.15 Insurance - participant 2.16.756.5.30.1.1.10.2.15 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.16 Order Reference - inFulfillmentOf 2.16.756.5.30.1.1.10.2.16 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.18 Document Template Ids CDA-CH v2.0 - structuredBody 2.16.756.5.30.1.1.10.2.18 2019‑10‑17 15:21:50
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.18 Document Template Ids CDA-CH v2.0 - structuredBody 2.16.756.5.30.1.1.10.2.18 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.19 Document Confidentiality Code 2.16.756.5.30.1.1.10.2.19 2019‑09‑12 14:08:42
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.19 Document Confidentiality Code 2.16.756.5.30.1.1.10.2.19 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.20 Document Set Id and Version Number 2.16.756.5.30.1.1.10.2.20 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.22 Document Language 2.16.756.5.30.1.1.10.2.22 2019‑09‑12 14:28:13
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.22 Document Language 2.16.756.5.30.1.1.10.2.22 2019‑09‑12 14:27:38
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.22 Document Language 2.16.756.5.30.1.1.10.2.22 2019‑09‑12 14:25:02
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.22 Document Language 2.16.756.5.30.1.1.10.2.22 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.25 Document Realm 2.16.756.5.30.1.1.10.2.25 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.3 Custodian 2.16.756.5.30.1.1.10.2.3 2019‑10‑15 09:26:07
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.3 Custodian 2.16.756.5.30.1.1.10.2.3 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.4 Recipient - informationRecipient 2.16.756.5.30.1.1.10.2.4 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.46 Health Service - documentationOf 2.16.756.5.30.1.1.10.2.46 2019‑01‑01 20:53:33
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.46 Health Service - documentationOf 2.16.756.5.30.1.1.10.2.46 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.5 Legal Authenticator 2.16.756.5.30.1.1.10.2.5 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.6 Authenticator 2.16.756.5.30.1.1.10.2.6 2019‑01‑01 20:20:44
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.6 Authenticator 2.16.756.5.30.1.1.10.2.6 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.2.7 Data Enterer 2.16.756.5.30.1.1.10.2.7 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.3.2 Remarks Section - coded 2.16.756.5.30.1.1.10.3.2 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.4.29 External document 2.16.756.5.30.1.1.10.4.29 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.12 Assigned Entity Compilation with id 2.16.756.5.30.1.1.10.9.12 2019‑10‑24 16:41:55
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.12 Assigned Entity Compilation with id 2.16.756.5.30.1.1.10.9.12 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.14 Narrative Text Reference 2.16.756.5.30.1.1.10.9.14 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.16 Author Compilation with name, addr and telecom 2.16.756.5.30.1.1.10.9.16 2019‑10‑24 16:13:06
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.16 Author Compilation with name, addr and telecom 2.16.756.5.30.1.1.10.9.16 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.17 Assigned Entity Compilation with name, addr and telecom 2.16.756.5.30.1.1.10.9.17 2019‑10‑24 16:20:55
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.17 Assigned Entity Compilation with name, addr and telecom 2.16.756.5.30.1.1.10.9.17 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.20 PlayingEntity Compilation with name 2.16.756.5.30.1.1.10.9.20 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.21 Device Compilation with name 2.16.756.5.30.1.1.10.9.21 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.23 Author 2.16.756.5.30.1.1.10.9.23 2019‑09‑12 13:48:28
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.23 Author 2.16.756.5.30.1.1.10.9.23 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.24 Organization Compilation with name 2.16.756.5.30.1.1.10.9.24 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.26 Organization Compilation with GLN, name, addr and telecom 2.16.756.5.30.1.1.10.9.26 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.27 Organization Compilation with name, addr, telecom 2.16.756.5.30.1.1.10.9.27 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.30 Organization Compilation with GLN and name 2.16.756.5.30.1.1.10.9.30 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.32 Assigned Entity Compilation with id, name, addr, telecom, person and organization 2.16.756.5.30.1.1.10.9.32 2019‑10‑24 16:38:14
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.32 Assigned Entity Compilation with id, name, addr, telecom, person and organization 2.16.756.5.30.1.1.10.9.32 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.33 Organization Compilation with id, name, addr and telecom 2.16.756.5.30.1.1.10.9.33 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.48 Author Compilation with name 2.16.756.5.30.1.1.10.9.48 2019‑10‑24 15:57:29
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.48 Author Compilation with name 2.16.756.5.30.1.1.10.9.48 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.49 Original Text Reference 2.16.756.5.30.1.1.10.9.49 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.50 Assigned Entity Compilation with GLN, name, addr, telecom, person and organization 2.16.756.5.30.1.1.10.9.50 2019‑10‑24 16:50:31
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.50 Assigned Entity Compilation with GLN, name, addr, telecom, person and organization 2.16.756.5.30.1.1.10.9.50 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.51 Assigned Entity Compilation with GLN and name 2.16.756.5.30.1.1.10.9.51 2019‑10‑24 16:53:35
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.51 Assigned Entity Compilation with GLN and name 2.16.756.5.30.1.1.10.9.51 2018‑04‑18
CDA‑CH V2 link11 2.16.756.5.30.1.1.10.9.54 Author Compilation with id, name, addr and telecom 2.16.756.5.30.1.1.10.9.54 2020‑04‑28 12:02:52
CDA‑CH V2 Body Templates link11 2.16.756.5.30.1.1.10.3.53 Current Pregnancy Section - coded 2.16.756.5.30.1.1.10.3.53 2018‑04‑19
CDA‑CH V2 Body Templates link11 2.16.756.5.30.1.1.10.3.53 Current Pregnancy Section - coded 2.16.756.5.30.1.1.10.3.53 2016‑11‑12
CDA‑CH V2 Body Templates link11 2.16.756.5.30.1.1.10.3.53 Current Pregnancy Section - coded 2.16.756.5.30.1.1.10.3.53 2016‑11‑11
CDA‑CH‑VACD link11 2.16.756.5.30.1.1.10.2.67 Document Template Ids CDA-CH-VACD V2 for Swiss EPR 2.16.756.5.30.1.1.10.2.67 2020‑06‑26
CDA‑CH‑VACD link11 2.16.756.5.30.1.1.10.2.68 Human Patient - recordTarget 2.16.756.5.30.1.1.10.2.68 2020‑06‑26
CDA‑CH‑VACD link11 2.16.756.5.30.1.1.10.2.68 Human Patient - recordTarget 2.16.756.5.30.1.1.10.2.68 2018‑04‑19
CDA‑CH‑VACD link11 2.16.756.5.30.1.1.10.2.69 Masked Patient - recordTarget 2.16.756.5.30.1.1.10.2.69 2020‑06‑26
CDA‑CH‑VACD link11 2.16.756.5.30.1.1.10.2.69 Masked Patient - recordTarget 2.16.756.5.30.1.1.10.2.69 2018‑04‑19
CDA‑CH‑VACD link11 2.16.756.5.30.1.1.10.2.71 Document Template Ids CDA-CH-VACD V2 non Swiss EPR 2.16.756.5.30.1.1.10.2.71 2020‑06‑26
CDA‑CH‑VACD link11 2.16.756.5.30.1.1.10.4.101 Immunization Performer - performer Containment 2.16.756.5.30.1.1.10.4.101 2016‑11‑11
CDA‑CH‑VACD link11 2.16.756.5.30.1.1.10.4.95 Target Of The Immunization - Medication Target 2.16.756.5.30.1.1.10.4.95 2018‑04‑19
CDA‑CH‑VACD link11 2.16.756.5.30.1.1.10.4.95 Target Of The Immunization - Medication Target 2.16.756.5.30.1.1.10.4.95 2016‑11‑12
CDA‑CH‑VACD link11 2.16.756.5.30.1.1.10.4.96 Recommendation Category - Criterion 2.16.756.5.30.1.1.10.4.96 2018‑04‑19
CDA‑CH‑VACVD link11 2.16.756.5.30.1.1.10.4.84 Gestational Age At Birth 2.16.756.5.30.1.1.10.4.84 2020‑06‑26
CH‑PALM link11 2.16.756.5.30.1.1.10.4.10 Device - participant Containment 2.16.756.5.30.1.1.10.4.10 2019‑08‑20
CH‑PALM link11 2.16.756.5.30.1.1.10.4.10 Device - participant Containment 2.16.756.5.30.1.1.10.4.10 2017‑06‑21
CH‑PALM link11 2.16.756.5.30.1.1.10.4.18 Multimedia Embedded Content 2.16.756.5.30.1.1.10.4.18 2019‑08‑20
CH‑PALM link11 2.16.756.5.30.1.1.10.4.18 Multimedia Embedded Content 2.16.756.5.30.1.1.10.4.18 2017‑06‑21
CH‑PALM link11 2.16.756.5.30.1.1.10.4.27 Specimen Type 2.16.756.5.30.1.1.10.4.27 2019‑08‑20
CH‑PALM link11 2.16.756.5.30.1.1.10.4.27 Specimen Type 2.16.756.5.30.1.1.10.4.27 2017‑06‑21
CH‑PCC link11 2.16.756.5.30.1.1.10.4.102 Pregnancy Observation Delivery Date 2.16.756.5.30.1.1.10.4.102 2018‑04‑19
CH‑PCC link11 2.16.756.5.30.1.1.10.4.102 Pregnancy Observation Delivery Date 2.16.756.5.30.1.1.10.4.102 2016‑11‑12
CH‑PCC link11 2.16.756.5.30.1.1.10.4.84 Gestational Age At Birth 2.16.756.5.30.1.1.10.4.84 2018‑04‑19
IHE PCC TF2 Rev.11, 6.3.1.10.1 link11 2.16.756.5.30.1.1.10.2.63 Document Code 2.16.756.5.30.1.1.10.2.63 2020‑06‑26
IHE PCC TF2 Rev.11, 6.3.1.10.1 link11 2.16.756.5.30.1.1.10.2.63 Document Code 2.16.756.5.30.1.1.10.2.63 2018‑04‑19
IHE PCC TF2 Rev.11, 6.3.3.2.11 link11 2.16.756.5.30.1.1.10.3.51 Allergies and other Adverse Reactions Section - coded 2.16.756.5.30.1.1.10.3.51 2016‑11‑12
IHE PCC TF2 Rev.11, 6.3.3.2.11 link11 2.16.756.5.30.1.1.10.3.51 Allergies and other Adverse Reactions Section - coded 2.16.756.5.30.1.1.10.3.51 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.3.2.3 link11 2.16.756.5.30.1.1.10.3.25 Active Problems Section - coded 2.16.756.5.30.1.1.10.3.25 2016‑11‑12
IHE PCC TF2 Rev.11, 6.3.3.2.3 link11 2.16.756.5.30.1.1.10.3.25 Active Problems Section - coded 2.16.756.5.30.1.1.10.3.25 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.3.2.5 link11 2.16.756.5.30.1.1.10.3.50 History Of Past Illness Section - coded 2.16.756.5.30.1.1.10.3.50 2016‑11‑12
IHE PCC TF2 Rev.11, 6.3.3.2.5 link11 2.16.756.5.30.1.1.10.3.50 History Of Past Illness Section - coded 2.16.756.5.30.1.1.10.3.50 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.3.3.5 link11 2.16.756.5.30.1.1.10.3.47 Immunizations Section - coded 2.16.756.5.30.1.1.10.3.47 2016‑11‑12
IHE PCC TF2 Rev.11, 6.3.3.3.5 link11 2.16.756.5.30.1.1.10.3.47 Immunizations Section - coded 2.16.756.5.30.1.1.10.3.47 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.3.5.2 link11 2.16.756.5.30.1.1.10.3.46 Other Relevant Observations Section - coded 2.16.756.5.30.1.1.10.3.46 2020‑06‑26
IHE PCC TF2 Rev.11, 6.3.3.5.2 link11 2.16.756.5.30.1.1.10.3.46 Other Relevant Observations Section - coded 2.16.756.5.30.1.1.10.3.46 2018‑04‑19
IHE PCC TF2 Rev.11, 6.3.3.6.13 link11 2.16.756.5.30.1.1.10.3.48 Immunization Recommendations Section - coded 2.16.756.5.30.1.1.10.3.48 2016‑11‑12
IHE PCC TF2 Rev.11, 6.3.3.6.13 link11 2.16.756.5.30.1.1.10.3.48 Immunization Recommendations Section - coded 2.16.756.5.30.1.1.10.3.48 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.4.12 link11 2.16.756.5.30.1.1.10.4.90 Problem Concern Entry 2.16.756.5.30.1.1.10.4.90 2016‑11‑12
IHE PCC TF2 Rev.11, 6.3.4.12 link11 2.16.756.5.30.1.1.10.4.90 Problem Concern Entry 2.16.756.5.30.1.1.10.4.90 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.4.13 link11 2.16.756.5.30.1.1.10.4.91 Allergies and Intolerances Concern Entry 2.16.756.5.30.1.1.10.4.91 2016‑11‑12
IHE PCC TF2 Rev.11, 6.3.4.13 link11 2.16.756.5.30.1.1.10.4.91 Allergies and Intolerances Concern Entry 2.16.756.5.30.1.1.10.4.91 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.4.14 link11 2.16.756.5.30.1.1.10.4.97 Problem Entry 2.16.756.5.30.1.1.10.4.97 2016‑11‑12
IHE PCC TF2 Rev.11, 6.3.4.14 link11 2.16.756.5.30.1.1.10.4.97 Problem Entry 2.16.756.5.30.1.1.10.4.97 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.4.15 link11 2.16.756.5.30.1.1.10.4.98 Allergy Or Intolerance Entry 2.16.756.5.30.1.1.10.4.98 2016‑11‑12
IHE PCC TF2 Rev.11, 6.3.4.15 link11 2.16.756.5.30.1.1.10.4.98 Allergy Or Intolerance Entry 2.16.756.5.30.1.1.10.4.98 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.4.15.10 link11 2.16.756.5.30.1.1.10.4.120 Reaction Observation 2.16.756.5.30.1.1.10.4.120 2020‑04‑29 12:47:35
IHE PCC TF2 Rev.11, 6.3.4.15.10 link11 2.16.756.5.30.1.1.10.4.120 Reaction Observation 2.16.756.5.30.1.1.10.4.120 2016‑11‑12
IHE PCC TF2 Rev.11, 6.3.4.17 link11 2.16.756.5.30.1.1.10.4.89 Immunization Entry 2.16.756.5.30.1.1.10.4.89 2016‑11‑12
IHE PCC TF2 Rev.11, 6.3.4.17 link11 2.16.756.5.30.1.1.10.4.89 Immunization Entry 2.16.756.5.30.1.1.10.4.89 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.4.19 link11 2.16.756.5.30.1.1.10.4.94 Manufactured Product 2.16.756.5.30.1.1.10.4.94 2016‑11‑12
IHE PCC TF2 Rev.11, 6.3.4.19 link11 2.16.756.5.30.1.1.10.4.94 Manufactured Product 2.16.756.5.30.1.1.10.4.94 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.4.25 link11 2.16.756.5.30.1.1.10.4.92 Pregnancy Observation Entry 2.16.756.5.30.1.1.10.4.92 2016‑11‑12
IHE PCC TF2 Rev.11, 6.3.4.3 link11 2.16.756.5.30.1.1.10.4.99 Severity Entry 2.16.756.5.30.1.1.10.4.99 2016‑11‑12
IHE PCC TF2 Rev.11, 6.3.4.3 link11 2.16.756.5.30.1.1.10.4.99 Severity Entry 2.16.756.5.30.1.1.10.4.99 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.4.4 link11 2.16.756.5.30.1.1.10.4.100 Problem Status Observation 2.16.756.5.30.1.1.10.4.100 2016‑11‑12
IHE PCC TF2 Rev.11, 6.3.4.4 link11 2.16.756.5.30.1.1.10.4.100 Problem Status Observation 2.16.756.5.30.1.1.10.4.100 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.4.49 link11 2.16.756.5.30.1.1.10.4.93 Immunization Recommendation Entry 2.16.756.5.30.1.1.10.4.93 2016‑11‑12
IHE PCC TF2 Rev.11, 6.3.4.49 link11 2.16.756.5.30.1.1.10.4.93 Immunization Recommendation Entry 2.16.756.5.30.1.1.10.4.93 2016‑11‑11
IHE PCC TF2 Rev.11, 6.3.4.49.11 link11 2.16.756.5.30.1.1.10.4.119 Immunization Series Number 2.16.756.5.30.1.1.10.4.119 2020‑04‑28 10:47:56
IHE PCC TF2 Rev.11, 6.3.4.49.11 link11 2.16.756.5.30.1.1.10.4.119 Immunization Series Number 2.16.756.5.30.1.1.10.4.119 2016‑11‑12
IHE PCC TF2 Rev.11, 6.3.4.6 link11 2.16.756.5.30.1.1.10.4.2 Annotation Comments 2.16.756.5.30.1.1.10.4.2 2016‑11‑12
IHE PCC TF2 Rev.11, 6.3.4.6 link11 2.16.756.5.30.1.1.10.4.2 Annotation Comments 2.16.756.5.30.1.1.10.4.2 2016‑11‑11
IHE PalM TF3 Rev.10, 6.3.2.16 link11 2.16.756.5.30.1.1.10.4.8 Laboratory Results Validator - participant Containment 2.16.756.5.30.1.1.10.4.8 2019‑08‑20
IHE PalM TF3 Rev.10, 6.3.2.20 link11 2.16.756.5.30.1.1.10.4.7 Laboratory Performer - performer Containment 2.16.756.5.30.1.1.10.4.7 2019‑08‑20
IHE PalM TF3 Rev.10, 6.3.3.1 link11 2.16.756.5.30.1.1.10.3.3 Laboratory Speciality Section - coded 2.16.756.5.30.1.1.10.3.3 2019‑08‑20
IHE PalM TF3 Rev.10, 6.3.3.2 link11 2.16.756.5.30.1.1.10.3.5 Laboratory Report Item Section - coded 2.16.756.5.30.1.1.10.3.5 2019‑08‑20
IHE PalM TF3 Rev.10, 6.3.4.10 link11 2.16.756.5.30.1.1.10.4.16 Outbreak Identification 2.16.756.5.30.1.1.10.4.16 2019‑08‑20
IHE PalM TF3 Rev.10, 6.3.4.11 link11 2.16.756.5.30.1.1.10.4.17 Laboratory Isolate Organizer 2.16.756.5.30.1.1.10.4.17 2019‑08‑20
IHE PalM TF3 Rev.10, 6.3.4.12 link11 2.16.756.5.30.1.1.10.4.19 Laboratory Battery Organizer 2.16.756.5.30.1.1.10.4.19 2019‑08‑20
IHE PalM TF3 Rev.10, 6.3.4.13 link11 2.16.756.5.30.1.1.10.4.22 Previous Observation 2.16.756.5.30.1.1.10.4.22 2019‑08‑20
IHE PalM TF3 Rev.10, 6.3.4.13 link11 2.16.756.5.30.1.1.10.4.3 Laboratory Observation 2.16.756.5.30.1.1.10.4.3 2019‑08‑20
IHE PalM TF3 Rev.10, 6.3.4.16 link11 2.16.756.5.30.1.1.10.4.9 Responsible Party - participant Containment 2.16.756.5.30.1.1.10.4.9 2019‑08‑20
IHE PalM TF3 Rev.10, 6.3.4.2 link11 2.16.756.5.30.1.1.10.4.4 Laboratory Report Data Processing Entry 2.16.756.5.30.1.1.10.4.4 2019‑08‑20
IHE PalM TF3 Rev.10, 6.3.4.3 link11 2.16.756.5.30.1.1.10.4.5 Non-Human Subject - subject Containment 2.16.756.5.30.1.1.10.4.5 2019‑08‑20
IHE PalM TF3 Rev.10, 6.3.4.4 link11 2.16.756.5.30.1.1.10.4.6 Human Patient with Non-Human Subject - subject Containment 2.16.756.5.30.1.1.10.4.6 2019‑08‑20
IHE PalM TF3 Rev.10, 6.3.4.5 link11 2.16.756.5.30.1.1.10.4.11 Specimen Collection 2.16.756.5.30.1.1.10.4.11 2019‑08‑20
IHE PalM TF3 Rev.10, 6.3.4.5 link11 2.16.756.5.30.1.1.10.4.24 Specimen collection - participant Containment 2.16.756.5.30.1.1.10.4.24 2019‑08‑20
IHE PalM TF3 Rev.10, 6.3.4.6 link11 2.16.756.5.30.1.1.10.4.12 Specimen Received 2.16.756.5.30.1.1.10.4.12 2019‑08‑20
IHE PalM TF3 Rev.10, 6.3.4.7 link11 2.16.756.5.30.1.1.10.4.13 Notification Organizer 2.16.756.5.30.1.1.10.4.13 2019‑08‑20
IHE PalM TF3 Rev.10, 6.3.4.8 link11 2.16.756.5.30.1.1.10.4.14 Notifiable Condition 2.16.756.5.30.1.1.10.4.14 2019‑08‑20
IHE PalM TF3 Rev.10, 6.3.4.9 link11 2.16.756.5.30.1.1.10.4.15 Case Identification 2.16.756.5.30.1.1.10.4.15 2019‑08‑20
IHE PalM TF3 Rev.8 link11 2.16.756.5.30.1.1.10.4.9 Responsible Party - participant Containment 2.16.756.5.30.1.1.10.4.9 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.2.16 link11 2.16.756.5.30.1.1.10.4.8 Laboratory Results Validator - authenticator/participant Containment 2.16.756.5.30.1.1.10.4.8 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.2.20 link11 2.16.756.5.30.1.1.10.4.7 Laboratory Performer - performer Containment 2.16.756.5.30.1.1.10.4.7 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.3.1 link11 2.16.756.5.30.1.1.10.3.3 Laboratory Speciality Section - coded 2.16.756.5.30.1.1.10.3.3 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.3.2 link11 2.16.756.5.30.1.1.10.3.5 Laboratory Report Item Section - coded 2.16.756.5.30.1.1.10.3.5 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.10 link11 2.16.756.5.30.1.1.10.4.16 Outbreak Identification 2.16.756.5.30.1.1.10.4.16 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.11 link11 2.16.756.5.30.1.1.10.4.17 Laboratory Isolate Organizer 2.16.756.5.30.1.1.10.4.17 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.12 link11 2.16.756.5.30.1.1.10.4.19 Laboratory Battery Organizer 2.16.756.5.30.1.1.10.4.19 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.13 link11 2.16.756.5.30.1.1.10.4.22 Previous Observation 2.16.756.5.30.1.1.10.4.22 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.13 link11 2.16.756.5.30.1.1.10.4.3 Laboratory Observation 2.16.756.5.30.1.1.10.4.3 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.2 link11 2.16.756.5.30.1.1.10.4.4 Laboratory Report Data Processing Entry 2.16.756.5.30.1.1.10.4.4 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.3 link11 2.16.756.5.30.1.1.10.4.5 Non-Human Subject - subject Containment 2.16.756.5.30.1.1.10.4.5 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.4 link11 2.16.756.5.30.1.1.10.4.6 Human Patient with Non-Human Subject - subject Containment 2.16.756.5.30.1.1.10.4.6 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.5 link11 2.16.756.5.30.1.1.10.4.11 Specimen Collection 2.16.756.5.30.1.1.10.4.11 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.5 link11 2.16.756.5.30.1.1.10.4.24 Specimen collection - participant Containment 2.16.756.5.30.1.1.10.4.24 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.6 link11 2.16.756.5.30.1.1.10.4.12 Specimen Received 2.16.756.5.30.1.1.10.4.12 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.7 link11 2.16.756.5.30.1.1.10.4.13 Notification Organizer 2.16.756.5.30.1.1.10.4.13 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.8 link11 2.16.756.5.30.1.1.10.4.14 Notifiable Condition 2.16.756.5.30.1.1.10.4.14 2017‑06‑21
IHE PalM TF3 Rev.8, 6.3.4.9 link11 2.16.756.5.30.1.1.10.4.15 Case Identification 2.16.756.5.30.1.1.10.4.15 2017‑06‑21
eCH‑0010 V7.0 addressInformation link11 2.16.756.5.30.1.1.10.9.35 Address Information Compilation - eCH-0010 2.16.756.5.30.1.1.10.9.35 2018‑04‑18
eCH‑0011 V8.1 nameData link11 2.16.756.5.30.1.1.10.9.34 Person Name Information Compilation - eCH-0011 2.16.756.5.30.1.1.10.9.34 2018‑04‑18

Data sets, codes, OIDs and Rules: this information is used for rendering and validation purposes.